Open AccessRadioembolization of Secondary Hepatic Malignancies
Author(s) -
Barbara Manchec,
Nima Kokabi,
Govindarajan Narayanan,
A. Niekamp,
Constantino Peña,
Alex Powell,
Brian J. Schiro,
Ripal Gandhi
Publication year - 2021
Publication title -
seminars in interventional radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.35
H-Index - 40
eISSN - 1098-8963
pISSN - 0739-9529
DOI - 10.1055/s-0041-1732318
Subject(s) - medicine , malignancy , colorectal cancer , metastasis , metastatic breast cancer , cancer , radiology , histopathology , oncology , breast cancer , pathology
Cancer has become the leading cause of mortality in America, and the majority of patients eventually develop hepatic metastasis. As liver metastases are frequently unresectable, the value of liver-directed therapies, such as transarterial radioembolization (TARE), has become increasingly recognized as an integral component of patient management. Outcomes after radioembolization of hepatic malignancies vary not only by location of primary malignancy but also by tumor histopathology. This article reviews the outcomes of TARE for the treatment of metastatic colorectal cancer, metastatic breast cancer, and metastatic neuroendocrine tumors, as well as special considerations when treating metastatic disease with TARE.